Actively Recruiting
Performance of Spectral CT-scan in Patients With Metastatic Colorectal Cancer: a Prospective Multicentre Study
Led by Centre Hospitalier Universitaire de Saint Etienne · Updated on 2024-09-20
100
Participants Needed
1
Research Sites
103 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Spectral CT is a rapidly expanding imaging modality that allows a reduction in iodine dose and irradiation compared to conventional scanning. It uses the difference in attenuation of the material according to the two different energy levels of the incident x-ray beams. The dual-energy scanner has a wide range of clinical applications, particularly in abdominal imaging.
CONDITIONS
Official Title
Performance of Spectral CT-scan in Patients With Metastatic Colorectal Cancer: a Prospective Multicentre Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients followed for colorectal cancer with synchronous or metachronous liver metastases and/or peritoneal carcinosis
- Patients with a curative surgical resection plan
You will not qualify if you...
- Patients with non-metastatic colorectal cancer
- Patients treated with chemotherapy without surgical plans
- Patients with colorectal cancer with extra-hepatic and extra-peritoneal metastases alone (e.g. lung, bone)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Saint-Etienne
Saint-Etienne, France, 42000
Actively Recruiting
Research Team
R
Rémi GRANGE, MD
CONTACT
S
Sylvain GRANGE, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here